38 results
8-K
EX-1.1
ACXP
Acurx Pharmaceuticals, Inc.
15 Nov 23
Entry into a Material Definitive Agreement
5:02pm
, arbitration, investigation, litigation or governmental proceeding pending or, to the Company’s knowledge, threatened against, or involving … of any term of any such Authorizations; (D) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation
8-K
EX-10.1
iq70pv
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-1.1
hwehb74 qjqz3bg6
17 May 23
Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering
4:19pm
8-K
EX-10.1
4lkvj8ulpvdud 86
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
8-K
EX-1.1
61l 10i7m
25 Jul 22
Acurx Pharmaceuticals, Inc. Announces $4.225 Million Registered Direct Offering
8:46am
S-3
EX-4.5
6nfy5 a8ins
1 Jul 22
Shelf registration
8:46am
S-3
EX-4.6
spuwxtff1fcxr42iyey
1 Jul 22
Shelf registration
8:46am
10-K
bd585m3
16 Mar 22
Annual report
4:05pm
10-Q
hk1b0wu9m6d97en4a6l
13 Aug 21
Quarterly report
4:06pm